Atlanta, GA – Scibility Media – 10/14/2014
This article discusses two companies with disparate bid and offer prices: IHS Inc.(NYSE:IHS) and IMS Health Holdings Inc.(NYSE:IMS)
IHS Inc.(NYSE:IHS) is a Colorado-based information and delivery science company that provides solutions for consumer workflows. On Oct. 13th, the company announced that Carfax, one of the company’s units, had expanded its partnership with the Ford Motor Company, through which the latter company will be providing Carfax reports to buyers and sellers of certified Ford and Lincoln Vehicles at no charge.
Additionally, Houston-based company announced that it had launched the latest release of IHS Connect on Oct. 2nd. The service is used to provide access to the company’s multidisciplinary information and insight.
IHS Inc. currently has a bid price of $115.55 x 100 and an offer price of $127.57 x 100, which means the company’s value could fluctuate in the near future.
On Oct. 10th, IMS Health Holdings Inc(NYSE:IMS) announced that the company would be reporting its third quarter financial results on Oct. 24th, 2014. The report will be released before the markets open and the company will host a conference call at 9AM EST on that date.
The company currently has a bid price of $20.53 x 100 and $30.14 x 600, figures that suggest that the information technology services business’s value is highly liquid. Interestingly, the company’s bid price exceeds its 52 week high by $1.66.
Topeka Capital Markets also initiated coverage of the company, assigning a rating of “Buy”, on Sept. 24th, 2014. Since that time, the stock’s value has fallen $2.16.
EquiPress.com is a non-advertisement based network (currently in limited release) designed for investors to discover and communicate with publicly traded companies in real-time.
Sign-up for free now to experience the full benefits of EquiPress pre-launch.
Discover and communicate with companies you would otherwise never have seen based on your interests, company news, personalized news feeds, and one-on-one communications with no middle-men nor advertisements. Read our no advertisements pledge.
Can’t find your company on EquiPress? Send us an email to email@example.com and we will contact them for you.
Interested in a one month free trial? Get access to our private investor network, real-time news distribution, automatic disclaimers, corporate analytics, verified public profile, and industry-wide marketing of your corporate news.
Disclosure: EquiPress is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. EquiPress does not hold any equity or financial interest in any publicly traded company. If a company mentioned in this article is a client of EquiPress, we will explicitly state the relationship. EquiPress provides a uniform subscription based service to all publicly traded companies on a monthly basis at a rate of $495 to provide investor awareness. EquiPress receives only cash compensation from clients. Despite the relationship, EquiPress maintains a neutral stance (nonbiased) on any investment related opinions and exists solely for the purpose of allowing investors to communicate with the publicly traded companies in an effort to establish for themselves investment considerations. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor. Please visit www.equipress.com for complete risks and disclosures.